Israel Chemicals (NYSE:ICL) was upgraded by investment analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, Marketbeat.com reports.

ICL has been the topic of several other reports. Zacks Investment Research raised Israel Chemicals from a “hold” rating to a “buy” rating and set a $5.00 target price on the stock in a report on Wednesday, March 7th. ValuEngine raised Israel Chemicals from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Finally, TheStreet raised Israel Chemicals from a “c+” rating to a “b-” rating in a report on Friday, March 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $5.00.

How to Become a New Pot Stock Millionaire

ICL stock opened at $4.22 on Wednesday. The company has a market capitalization of $5,521.69, a PE ratio of 15.07 and a beta of 1.06. Israel Chemicals has a twelve month low of $3.85 and a twelve month high of $4.95. The company has a current ratio of 1.17, a quick ratio of 0.64 and a debt-to-equity ratio of 0.82.

Israel Chemicals (NYSE:ICL) last announced its earnings results on Wednesday, February 14th. The basic materials company reported $0.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.03. The firm had revenue of $1.36 billion for the quarter. Israel Chemicals had a return on equity of 13.88% and a net margin of 6.72%. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.09 earnings per share. equities analysts anticipate that Israel Chemicals will post 0.34 earnings per share for the current fiscal year.

Several hedge funds have recently bought and sold shares of the company. Meitav Dash Investments Ltd. bought a new position in shares of Israel Chemicals in the 4th quarter worth about $24,290,000. Delek Group Ltd. bought a new position in shares of Israel Chemicals in the 4th quarter worth about $16,093,000. Arrowstreet Capital Limited Partnership raised its position in shares of Israel Chemicals by 65.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,065,779 shares of the basic materials company’s stock worth $12,421,000 after acquiring an additional 1,209,368 shares in the last quarter. Swiss National Bank raised its position in shares of Israel Chemicals by 0.7% in the 4th quarter. Swiss National Bank now owns 1,966,371 shares of the basic materials company’s stock worth $7,993,000 after acquiring an additional 13,758 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Israel Chemicals by 32.2% in the 4th quarter. Bank of New York Mellon Corp now owns 1,823,853 shares of the basic materials company’s stock worth $732,871,000 after acquiring an additional 444,673 shares in the last quarter. 7.96% of the stock is owned by hedge funds and other institutional investors.

WARNING: This report was originally reported by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.watchlistnews.com/citigroup-upgrades-israel-chemicals-icl-to-buy/1958817.html.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.